164 related articles for article (PubMed ID: 38349312)
1. Modeling the selective growth advantage of genetically variant human pluripotent stem cells to identify opportunities for manufacturing process control.
Beltran-Rendon C; Price CJ; Glen K; Stacey A; Barbaric I; Thomas RJ
Cytotherapy; 2024 Apr; 26(4):383-392. PubMed ID: 38349312
[TBL] [Abstract][Full Text] [Related]
2. Genetically variant human pluripotent stem cells selectively eliminate wild-type counterparts through YAP-mediated cell competition.
Price CJ; Stavish D; Gokhale PJ; Stevenson BA; Sargeant S; Lacey J; Rodriguez TA; Barbaric I
Dev Cell; 2021 Sep; 56(17):2455-2470.e10. PubMed ID: 34407428
[TBL] [Abstract][Full Text] [Related]
3. Culture conditions affect cardiac differentiation potential of human pluripotent stem cells.
Ojala M; Rajala K; Pekkanen-Mattila M; Miettinen M; Huhtala H; Aalto-Setälä K
PLoS One; 2012; 7(10):e48659. PubMed ID: 23119085
[TBL] [Abstract][Full Text] [Related]
4. Hydrogel-Based Bioprocess for Scalable Manufacturing of Human Pluripotent Stem Cell-Derived Neural Stem Cells.
Lin H; Du Q; Li Q; Wang O; Wang Z; Liu K; Elowsky C; Zhang C; Lei Y
ACS Appl Mater Interfaces; 2018 Sep; 10(35):29238-29250. PubMed ID: 30091584
[TBL] [Abstract][Full Text] [Related]
5. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.
Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y
Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125
[TBL] [Abstract][Full Text] [Related]
6. Assessing Cell Competition in Human Pluripotent Stem Cell (hPSC) Cultures.
Price CJ; Barbaric I
Curr Protoc; 2022 May; 2(5):e435. PubMed ID: 35621694
[TBL] [Abstract][Full Text] [Related]
7. High density bioprocessing of human pluripotent stem cells by metabolic control and in silico modeling.
Manstein F; Ullmann K; Kropp C; Halloin C; Triebert W; Franke A; Farr CM; Sahabian A; Haase A; Breitkreuz Y; Peitz M; Brüstle O; Kalies S; Martin U; Olmer R; Zweigerdt R
Stem Cells Transl Med; 2021 Jul; 10(7):1063-1080. PubMed ID: 33660952
[TBL] [Abstract][Full Text] [Related]
8. Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity.
Apáti Á; Varga N; Berecz T; Erdei Z; Homolya L; Sarkadi B
Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):61-75. PubMed ID: 30526128
[No Abstract] [Full Text] [Related]
9. Female human pluripotent stem cells rapidly lose X chromosome inactivation marks and progress to a skewed methylation pattern during culture.
Geens M; Seriola A; Barbé L; Santalo J; Veiga A; Dée K; Van Haute L; Sermon K; Spits C
Mol Hum Reprod; 2016 Apr; 22(4):285-98. PubMed ID: 26786180
[TBL] [Abstract][Full Text] [Related]
10. Single cell heterogeneity in human pluripotent stem cells.
Yang S; Cho Y; Jang J
BMB Rep; 2021 Oct; 54(10):505-515. PubMed ID: 34488931
[TBL] [Abstract][Full Text] [Related]
11. Culturing human pluripotent stem cells for regenerative medicine.
Ozawa H; Matsumoto T; Nakagawa M
Expert Opin Biol Ther; 2023; 23(6):479-489. PubMed ID: 37345510
[TBL] [Abstract][Full Text] [Related]
12. Exploring the effects of cell seeding density on the differentiation of human pluripotent stem cells to brain microvascular endothelial cells.
Wilson HK; Canfield SG; Hjortness MK; Palecek SP; Shusta EV
Fluids Barriers CNS; 2015 May; 12():13. PubMed ID: 25994964
[TBL] [Abstract][Full Text] [Related]
13. Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells.
Chen VC; Ye J; Shukla P; Hua G; Chen D; Lin Z; Liu JC; Chai J; Gold J; Wu J; Hsu D; Couture LA
Stem Cell Res; 2015 Sep; 15(2):365-75. PubMed ID: 26318718
[TBL] [Abstract][Full Text] [Related]
14. The combination of dextran sulphate and polyvinyl alcohol prevents excess aggregation and promotes proliferation of pluripotent stem cells in suspension culture.
Tang X; Wu H; Xie J; Wang N; Chen Q; Zhong Z; Qiu Y; Wang J; Li X; Situ P; Lai L; Zern MA; Chen H; Duan Y
Cell Prolif; 2021 Sep; 54(9):e13112. PubMed ID: 34390064
[TBL] [Abstract][Full Text] [Related]
15. Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors.
Kropp C; Kempf H; Halloin C; Robles-Diaz D; Franke A; Scheper T; Kinast K; Knorpp T; Joos TO; Haverich A; Martin U; Zweigerdt R; Olmer R
Stem Cells Transl Med; 2016 Oct; 5(10):1289-1301. PubMed ID: 27369897
[TBL] [Abstract][Full Text] [Related]
16.
Riggs MJ; Sheridan SD; Rao RR
Stem Cells Dev; 2021 Jul; 30(14):705-713. PubMed ID: 34036793
[TBL] [Abstract][Full Text] [Related]
17. A novel in vitro method for detecting undifferentiated human pluripotent stem cells as impurities in cell therapy products using a highly efficient culture system.
Tano K; Yasuda S; Kuroda T; Saito H; Umezawa A; Sato Y
PLoS One; 2014; 9(10):e110496. PubMed ID: 25347300
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions.
Meng G; Liu S; Rancourt DE
Stem Cells Dev; 2012 Jul; 21(11):2036-48. PubMed ID: 22149941
[TBL] [Abstract][Full Text] [Related]
19. Modulating cell state to enhance suspension expansion of human pluripotent stem cells.
Lipsitz YY; Woodford C; Yin T; Hanna JH; Zandstra PW
Proc Natl Acad Sci U S A; 2018 Jun; 115(25):6369-6374. PubMed ID: 29866848
[TBL] [Abstract][Full Text] [Related]
20. Engineered hematopoietic and immune cells derived from human pluripotent stem cells.
Chang Y; Hummel SN; Jung J; Jin G; Deng Q; Bao X
Exp Hematol; 2023 Nov; 127():14-27. PubMed ID: 37611730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
